January 18, 2009
IPA FAQs About the Myozyme Supply Problem
A compilation of the most pertinent information regarding the Myozyme supply issue. The IPA has done its best to gather
January 17, 2009
AMDA Statement Regarding the Management of “Myozyme” supply
The AMDA is writing to our Pompe patient community to let everyone know that the AMDA has been working closely
The European Medicines Agency’s (EMEA) Committee for Medicinal Products (CHMP) has recommended that infants, children and adolescents be given priority
January 14, 2009
IPA Statement Regarding the Management of Myozyme Supply
Since the first market approval of Myozyme, the IPA has liaised directly with Genzyme LSD Therapeutics to insist that an
Since the first market approval of Myozyme, the IPA has liaised directly with Genzyme LSD Therapeutics to insist that an